Verified Sponsor Execution & Regulatory Ledger
| Sponsor Metric | Verified Count / Rate |
|---|---|
| Phase II & III Protocols (2018 to 2026) | 41 |
| Active Pipeline (Recruiting Now) | 18 (14) |
| Completed vs Stopped Early | 16 / 7 (17.1%) |
| Median Closed Actual Enrollment | 47 participants |
| Physical Hospital Site Disclosure | 100.0% named hospitals |
| FDA Drugs@FDA Original NDA/BLA Approvals | 0 (0 since 2018) |
Top Partner U.S. Hospital Clinical Research Sites
| Hospital Research Site | Location | Shared Protocols |
|---|---|---|
| Beth Israel Deaconess Medical Center | Boston, MA | 36 |
| Massachusetts General Hospital | Boston, MA | 5 |
| Brigham and Women's Hospital | Boston, MA | 4 |
Indexed Multi-Center Phase II & III Protocols
| NCT Identifier | Protocol Brief Title | Phase | Status |
|---|---|---|---|
| NCT06066502 | Precision Ventilation vs Standard Care for Acute Respiratory Distress Syndrome | Phase III | RECRUITING |
| NCT04093219 | PANDORA: Delirium Prevention After Cardiac Surgery Using IV Acetaminophen to Prevent Postoperative Delirium in Older Cardiac Surgical Patien | Phase III | COMPLETED |
Explore interactive annual charts and M&A subsidiary rollups in the Beth Israel Deaconess Medical Center Interactive Dossier, benchmark peers in Oncology and Hematology, or review the Healthcare Price & Patent Cliff Crosswalk.